IMMUCELL CORP /DE/ (ICCC) Insider Trading Disclosures
IMMUCELL CORP /DE/ (ICCC) is a publicly traded company on the Nasdaq, categorized under SIC 2835 (In Vitro & In Vivo Diagnostic Substances). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ICCC
CIK: 811641
Exchange: Nasdaq
SIC 2835: In Vitro & In Vivo Diagnostic Substances
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Wipfli LLP
Auditor SinceSince 12/31/2019 12:00:00 AM
Lead Engagement PartnerTracy Heideman
Audit LocationRadnor, Pennsylvania, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-13 | 2026-10-12 | FORM 8-K | 0001437749-26-032465 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | FORM 10-Q | 0001437749-26-027668 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-13 | FORM 8-K | 0001437749-26-027667 | View SEC Doc Filr Page |
| 8-K | 2026-07-09 | 2026-07-09 | FORM 8-K | 0001437749-26-023199 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-18 | FORM 4 TE BOEKHORST, OLIVIER | 0001437749-26-021258 | View SEC Doc Filr Page |
| 8-K | 2026-06-17 | 2026-06-11 | FORM 8-K | 0001437749-26-020926 | View SEC Doc Filr Page |
| 8-K | 2026-06-10 | 2026-06-04 | FORM 8-K | 0001437749-26-020154 | View SEC Doc Filr Page |
| 8-K | 2026-05-14 | 2026-05-14 | FORM 8-K | 0001437749-26-017049 | View SEC Doc Filr Page |
| 10-Q | 2026-05-14 | 2026-03-31 | FORM 10-Q | 0001437749-26-017045 | View SEC Doc Filr Page |
| 10-K/A | 2026-05-13 | 2025-12-31 | FORM 10-K/A | 0001437749-26-016719 | View SEC Doc Filr Page |
| 8-K | 2026-05-08 | 2026-05-08 | FORM 8-K | 0001437749-26-015945 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-24 | 2026-06-11 | FORM DEF 14A | 0001437749-26-013234 | View SEC Doc Filr Page |
| 3 | 2026-04-23 | 2026-04-15 | FORM 3 DIMARCO, ANTHONY 04/23/26 | 0001437749-26-013122 | View SEC Doc Filr Page |
| 3 | 2026-04-23 | 2026-04-15 | FORM 3 GUILLEMETTE, GILLES 04-23-2026 | 0001437749-26-013118 | View SEC Doc Filr Page |
| 4 | 2026-04-16 | 2026-04-15 | FORM 4 TURNER, KATHY 04/15/26 | 0001437749-26-012561 | View SEC Doc Filr Page |
| 4 | 2026-04-16 | 2026-04-15 | FORM 4, TOMSCHE, DAVID 04/15/26 | 0001437749-26-012557 | View SEC Doc Filr Page |
| 4 | 2026-04-16 | 2026-04-15 | FORM 4 BASSE GLORIA 04/15/26 | 0001437749-26-012554 | View SEC Doc Filr Page |
| 4 | 2026-04-16 | 2026-04-15 | FORM 4 WAINMAN, PAUL 04/15/26 | 0001437749-26-012551 | View SEC Doc Filr Page |
| PRE 14A | 2026-04-14 | 2026-06-11 | FORM PRE 14A | 0001437749-26-012259 | View SEC Doc Filr Page |
| 4 | 2026-04-14 | 2025-04-16 | FORM 4 GATHAGAN, BRYAN 04/14/26 | 0001437749-26-012240 | View SEC Doc Filr Page |
| 4 | 2026-04-14 | 2025-04-16 | FORM 4 WAINMAN, PAUL 04/16/26 | 0001437749-26-012238 | View SEC Doc Filr Page |
| 4 | 2026-04-14 | 2025-04-16 | FORM 4 TOMSCHE, DAVID 04/14/26 | 0001437749-26-012236 | View SEC Doc Filr Page |
| 4 | 2026-04-14 | 2025-04-16 | FORM 4 BROCKMANN, BOBBI 04/14/26 | 0001437749-26-012234 | View SEC Doc Filr Page |
| 4 | 2026-04-14 | 2025-04-16 | FORM 4 ROSGEN, STEVEN 04/14/26 | 0001437749-26-012232 | View SEC Doc Filr Page |
| 4 | 2026-04-14 | 2025-04-16 | FORM 4 BASSE GLORIA 04/14/26 | 0001437749-26-012230 | View SEC Doc Filr Page |